Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

Coinbase Vice Chair Ryan Vangrack Talks CLARITY Act
07:55

US Senate Candidate Abdul El-Sayed Talks Midterm Election
10:36

Nascar CEO Steve O'Donnell Talks Reshaping Business
08:34